HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2012

Oct 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-10-15

Reporting Person: Rosen Robert (Director, SVP & Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-15	Stock Option (right to buy)	$.62	A	10000000	Acquired	2022-10-15	Common Stock (10000000)	Direct

Footnotes

F1: Options will vest over a 41-month period from the date of grant pursuant to a vesting schedule set forth in the Reporting Person's employment agreement.